Quarterly report pursuant to Section 13 or 15(d)

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail)

v3.20.2
Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Mar. 31, 2020
[2]
Jun. 30, 2019
Mar. 31, 2019
[2]
Jun. 30, 2020
Jun. 30, 2019
Schedule Of Cash Flow Supplemental [Line Items]            
Cash paid for interest         $ 47,014 $ 47,015
Cash paid for income taxes, net of refunds received         5,229 36,831
Noncash investing and financing activities:            
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [1]         1,043 (16,118)
Investment in NCM – receipt of common units (see Note 9)         3,620 1,552
Dividends accrued on unvested restricted stock unit awards   $ (256) $ (189) [2] $ (108) (256) (297)
NCM            
Noncash investing and financing activities:            
Interest expense - NCM (see Note 9) $ (5,934)   $ (4,732)   $ (11,825) $ (9,514)
[1] Additions to theatre properties and equipment included in accounts payable as of June 30, 2020 and December 31, 2019 were $16,034 and $14,991, respectively.
[2]

Below is a summary of dividends paid to stockholders as well as dividends accrued on unvested restricted stock units during the six months ended June 30, 2020 and 2019: